Aethlon Medical, Inc.
AEMD
$1.18
-$0.02-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.39M | -9.56M | -11.27M | -11.50M | -12.21M |
| Total Depreciation and Amortization | 339.60K | 341.50K | 349.20K | 354.80K | 359.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.31M | 708.40K | 1.12M | 1.13M | 1.24M |
| Change in Net Operating Assets | 93.60K | -29.60K | 892.10K | 620.30K | 478.70K |
| Cash from Operations | -7.65M | -8.54M | -8.91M | -9.39M | -10.13M |
| Capital Expenditure | 0.00 | -7.10K | -13.70K | -20.50K | -250.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -7.10K | -13.70K | -20.50K | -250.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.91M | 5.43M | 5.62M | 5.62M | 1.32M |
| Repurchase of Common Stock | -18.90K | -23.20K | -25.50K | -31.50K | -34.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -164.90K | -- | -- | -- | -- |
| Cash from Financing | 7.73M | 5.41M | 5.60M | 5.59M | 1.29M |
| Foreign Exchange rate Adjustments | -12.20K | -12.10K | 7.10K | 900.00 | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.60K | -3.15M | -3.32M | -3.83M | -9.09M |